Integra LifeSciences (IART) PT Raised to $60 at Credit Suisse
Tweet
Share
E-mailGet Alerts IART Hot Sheet
Price: $16.66 -0.18%
Rating Summary:
8 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 9 | New: 13
Rating Summary:
8 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 9 | New: 13
Join SI Premium – FREE
Credit Suisse analyst Matt Miksic raised the price target on Integra LifeSciences (NASDAQ: IART) to $60.00 (from $58.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Calumet Specialty Products Partners (CLMT) PT Raised to $47 at UBS
- BXP Inc. (BXP) PT Raised to $70 at UBS as Earnings Outlook Accelerates
- Global-E Online Ltd (GLBE) PT Raised to $47 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
